Migdalia Zambrano

Migdalia Zambrano has a diverse work experience in the pharmaceutical industry. Migdalia started their career in 2002 at Sentrx/Pfizer as a Global Safety Surv. Monitor. Migdalia then moved on to DOV Pharmaceutical in 2006 as a Safety Monitor. In the same year, they joined Novartis Pharma as a Senior Clinical Manager. Migdalia worked there until 2009 when they transitioned to Novartis as an Expert Clinical Manager. In 2015, Migdalia joined Stemline Therapeutics Inc. as a Project Lead/Senior Manager. Later that year, they became a Clinical Project Lead/Sr. Manager at the same company. Migdalia's expertise lies in clinical management and safety monitoring in the pharmaceutical industry.

Migdalia Zambrano obtained a Master of Science degree in Health Care Management from Saint Elizabeth University, where they studied from 2011 to 2014. Prior to that, they earned a BA degree in Biology, with a minor in Chemistry, from New York University. Furthermore, Migdalia has an additional certification as a Certified Clinical Research Professional from BRANY, although the specific date of when they obtained this certification is not provided.